Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Chase

Showing results (11-20 of 397) with videos related to

Pageof 40
Sort By:
Advances in Biochemical Psychopharmacology|January 1, 1974
Clinical studies of dopaminergic mechanismsT N Chase
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1976
Rational approaches to the pharmacotherapy of choreaT N Chase
Neurology|December 1, 1970
Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonismT N Chase
Advances in Neurology|January 1, 1974
Serotonergic mechanisms and extrapyramidal function in manT N Chase
Drugs|March 4, 1998
The significance of continuous dopaminergic stimulation in the treatment of Parkinson's diseaseT N Chase
Archives of Neurology|October 1, 1972
Serotonergic mechanisms in Parkinson's diseaseT N Chase
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 1, 1986
Cerebral metabolic rate of glucose and Alzheimer's diseaseN Foster, T N Chase
Clinical Pharmacology and Therapeutics|May 1, 1975
Fenfluramine in man: hypophagia associated with diminished serotonin turnoverI Shoulson, T N Chase
Neuropharmacology|June 1, 1995
Effects of SCH 32615, an enkephalinase inhibitor, on D-1 and D-2 dopamine receptor-mediated behaviorsC Marin, T N Chase
Neuropharmacology|January 1, 1976
Clonidine and the anti-parkinsonian response to L-DOPA or piribedilI Shoulson, T N Chase
Pageof 40

Showing results (11-20 of 397) with videos related to

Sort By:
Pageof 40
Advances in Biochemical Psychopharmacology|January 1, 1974
Clinical studies of dopaminergic mechanismsT N Chase
Research Publications - Association for Research in Nervous and Mental Disease|January 1, 1976
Rational approaches to the pharmacotherapy of choreaT N Chase
Neurology|December 1, 1970
Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonismT N Chase
Advances in Neurology|January 1, 1974
Serotonergic mechanisms and extrapyramidal function in manT N Chase
Drugs|March 4, 1998
The significance of continuous dopaminergic stimulation in the treatment of Parkinson's diseaseT N Chase
Archives of Neurology|October 1, 1972
Serotonergic mechanisms in Parkinson's diseaseT N Chase
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 1, 1986
Cerebral metabolic rate of glucose and Alzheimer's diseaseN Foster, T N Chase
Clinical Pharmacology and Therapeutics|May 1, 1975
Fenfluramine in man: hypophagia associated with diminished serotonin turnoverI Shoulson, T N Chase
Neuropharmacology|June 1, 1995
Effects of SCH 32615, an enkephalinase inhibitor, on D-1 and D-2 dopamine receptor-mediated behaviorsC Marin, T N Chase
Neuropharmacology|January 1, 1976
Clonidine and the anti-parkinsonian response to L-DOPA or piribedilI Shoulson, T N Chase
Pageof 40